PolyPid Ltd
NASDAQ:PYPD
PolyPid Ltd
Cash from Investing Activities
PolyPid Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
PolyPid Ltd
NASDAQ:PYPD
|
Cash from Investing Activities
$3.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash from Investing Activities
$968m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash from Investing Activities
$148.1m
|
CAGR 3-Years
373%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cash from Investing Activities
-₪147.2m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-286%
|
CAGR 10-Years
-74%
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash from Investing Activities
-$34.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-28%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash from Investing Activities
-₪20.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
See Also
What is PolyPid Ltd's Cash from Investing Activities?
Cash from Investing Activities
3.8m
USD
Based on the financial report for Dec 31, 2023, PolyPid Ltd's Cash from Investing Activities amounts to 3.8m USD.
What is PolyPid Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-19%
Over the last year, the Cash from Investing Activities growth was -77%.